Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
40.98
-0.37 (-0.89%)
At close: Aug 17, 2026, 4:00 PM EDT
41.00
+0.02 (0.05%)
Pre-market: Aug 18, 2026, 7:36 AM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $2.57 billion as of August 18, 2026. Its market cap has increased by 361.40% in one year.
Market Cap
2.57B
Enterprise Value
2.50B
1-Year Change
361.40%
Ranking
Category
Stock Price
$40.98
ChartMarket Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $2.57B, an increase of 618.72%. That is a compound annual growth rate of 28.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 2.57B | 48.34% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 2.81B |
| AtaiBeckley | 2.69B |
| Beam Therapeutics | 2.67B |
| Trevi Therapeutics | 2.63B |
| Ultragenyx Pharmaceutical | 2.60B |
| SELLAS Life Sciences Group | 2.58B |
| Hemab Therapeutics Holdings | 2.57B |
| Viridian Therapeutics | 2.50B |